Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Labor drug under scrutiny: does it help or harm during pushing?

NCT ID NCT04303702

Summary

This study examines whether continuing the labor medication oxytocin during the pushing stage helps first-time mothers. Researchers want to see if it shortens pushing time and reduces the need for forceps, vacuum, or C-section deliveries. The study will also check if continuing oxytocin affects risks like heavy bleeding after birth or infections.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LABOR COMPLICATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Barnes Jewish Hospital

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.